Immunicon Corporation (NASDAQ IMMC) was a Huntingdon Valley, Pennsylvania biotechnology company that pioneered immunomagnetic cell-selection technology for isolating and characterizing rare circulating tumor cells (CTCs) from blood. - View it on GitHub